The findings indicate that SWEPFT-H exhibits superior efficacy in stimulating Akt1 and Slc2a2 transcription throughout liver tissue, thus facilitating the amelioration of hyperglycemic conditions in T2DM mice. This evidence concerns the gene AKT1 and type 2 diabetes mellitus.